Amyotrophic Lateral Sclerosis(ALS) Clinical Trials in Toronto, Ontario
3 recruitingToronto, Ontario, Canada
Showing 1–3 of 3 trials
Recruiting
Phase 2
Study of COYA 302 for the Treatment of ALS
Amyotrophic Lateral Sclerosis(ALS)
Coya Therapeutics120 enrolled25 locationsNCT07161999
Recruiting
Phase 1Phase 2
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
Amyotrophic Lateral Sclerosis(ALS)Mutation in the Superoxide Dismutase-1 (SOD1) Gene
Regeneron Pharmaceuticals42 enrolled16 locationsNCT06351592
Recruiting
Not Applicable
CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
QuadriplegiaSpinal Cord InjuryAmyotrophic Lateral Sclerosis(ALS)+4 more
Neuralink Corp6 enrolled1 locationNCT06700304